kabutan

SAWAI GROUP HOLDINGS Co.,Ltd.(4887) Summary

4887
TSE Prime
SAWAI GROUP HOLDINGS Co.,Ltd.
2,355.5
JPY
-6.5
(-0.28%)
Jan 29, 3:30 pm JST
15.39
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
2,344.4
Jan 29, 5:29 pm JST
Summary Chart Historical News Financial Result
PER
19.4
PBR
1.54
Yield
2.33%
Margin Trading Ratio
1.39
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
2,359.0 JPY 15.40 USD
Previous Close Jan 28
2,362.0 JPY 15.47 USD
High Jan 29, 9:00 am
2,369.5 JPY 15.47 USD
Low Jan 29, 9:18 am
2,340.5 JPY 15.29 USD
Volume
309,500
Trading Value
0.73B JPY 4.77M USD
VWAP
2356.64 JPY 15.41 USD
Minimum Trading Value
235,550 JPY 1,539 USD
Market Cap
0.27T JPY 1.79B USD
Number of Trades
1,112
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
1,612
1-Year High Feb 14, 2025
5,946
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 186,800 43,200 0.23
Jan 16, 2026 185,600 35,500 0.19
Jan 9, 2026 196,300 37,700 0.19
Dec 26, 2025 201,800 55,100 0.27
Dec 19, 2025 203,400 62,300 0.31
Company Profile
SAWAI GROUP HOLDINGS Co., Ltd. is a leading generic pharmaceutical company, specializing in lifestyle disease treatments and anti-cancer drugs. The company is focusing on expanding its business in the United States.
Sector
Pharmaceuticals
SAWAI GROUP HOLDINGS Co., Ltd. primarily engages in the manufacturing and sales of prescription and over-the-counter pharmaceuticals. The group consists of a holding company and eight consolidated subsidiaries, operating under a single segment of "manufacturing and sales of pharmaceuticals and related products." The core company, Sawai Pharmaceutical Co., Ltd., manufactures and sells pharmaceuticals to domestic distributors, wholesalers, other pharmaceutical manufacturers, and medical institutions. Medisa Shinyaku Co., Ltd. handles the sales of prescription drugs, while Kaken Shoyaku Co., Ltd. is responsible for the manufacturing and sales of prescription drugs and the supply of primary raw materials. Trust Pharmatech Co., Ltd. manufactures and sells prescription drugs and is entrusted with part of the research and development and manufacturing operations from Sawai Pharmaceutical. The group as a whole strives for efficient business operations and aims to strengthen its competitiveness in the pharmaceutical market.